Search Results - "Laskow, D."

A Phase I/II Randomized Open‐Label Multicenter Trial of Efalizumab, a Humanized Anti‐CD11a, Anti‐LFA‐1 in Renal Transplantation by Vincenti, F., Mendez, R., Pescovitz, M., Rajagopalan, P. R., Wilkinson, A. H., Butt, K., Laskow, D., Slakey, D. P., Lorber, M. I., Garg, J. P., Garovoy, M.

“…Leukocyte function associated antigen‐1 (LFA‐1) has a multifaceted role in the immune response, including adhesion and trafficking of leukocytes, stabilizing…”
Get full text

Spermatocele Following Kidney Transplant by Osband, A. J., Laskow, D. A.

“…Lymphocele following kidney transplant is a common occurrence, but on occasion, what appears to be a lymphocele is not. We present an unusual case of a kidney…”
Get full text

Treatment of Acute Graft-vs-Host Disease After Simultaneous Pancreas-Kidney Transplantation: A Case Report by Osband, A.J, Laskow, D.A, Mann, R.A

“…Abstract Whereas neutropenia is common after solid-organ transplantation, graft-vs-host disease is unusual, especially after simultaneous pancreas-kidney…”
Get full text

Sarcoidosis Within a Renal Allograft: A Case Report and Review of the Literature by Mann, D.M, Fyfe, B, Osband, A.J, Lebowitz, J, Laskow, D.A, Jones, J, Mann, R.A

“…Abstract Sarcoidosis is an unusual disorder of unknown etiology. Clinically apparent renal involvement is rare in sarcoidosis. The incidence of recurrence in…”
Get full text

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation : A report of the United States Multicenter FK506 Kidney Transplant group by LASKOW, D. A, VINCENTI, F, NEYLAN, J. F, MENDEZ, R, MATAS, A. J

“…This was a multicenter, open-label, concentration-ranging trial of FK506 and cyclosporine in 120 patients undergoing primary cadaveric kidney transplant…”
Get full text

Rapid Loss of Vertebral Mineral Density after Renal Transplantation by Julian, Bruce A, Laskow, David A, Dubovsky, Eva V, Dubovsky, Jiri, Curtis, John J, Quarles, L. Darryl

“…RENAL transplantation corrects many of the disturbances of calcium and phosphorus metabolism that lead to renal osteodystrophy in patients with chronic renal…”
Get full text

Sweet Syndrome After Kidney Transplantation by Osband, A.J, Laskow, D.A, Mann, R.A, Berkowicz, T, Ianosi-Irimie, M, Boruchoff, S

“…Abstract The association between Sweet syndrome (acute febrile neutrophilic dermatosis) and malignancies, infection, and drugs has been well established, but…”
Get full text

Transforming growth factor-β levels in human allograft chronic fibrosis correlate with rate of decline in renal function by CUHACI, B, KUMAR, M. S. A, STURGILL, B. C, PANKEWYCZ, O. G, BLOOM, R. D, PRATT, B, HAUSSMAN, G, LASKOW, D. A, ALIDOOST, M, GROTKOWSKI, C, CAHILL, K, BUTANI, L

“…Long-term renal transplant function is limited primarily by a progressive scarring process loosely termed "chronic rejection, chronic allograft nephropathy, or…”
Get full text

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation : A report of the U.S. Multicenter FK506 Kidney Transplant Group by VINCENTI, F, LASKOW, D. A, NEYLAN, J. F, MENDEZ, R, MATAS, A. J

“…Patients undergoing primary cadaveric kidney transplantation were followed for 1 year as part of a phase II, multicenter, open-label concentration-ranging…”
Get full text

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients by Barber, W H, Mankin, J A, Laskow, D A, Deierhoi, M H, Julian, B A, Curtis, J J, Diethelm, A G

“…Experimental studies have shown that antilymphocyte globulin combined with transfusion of donor-specific bone marrow cells can induce partial tolerance to…”
Get more information

Long-term function and survival of elderly donor kidneys transplanted into young adults by ANIL KUMAR, M. S, PANIGRAHI, D, DEZII, C. M, ABOUNA, G. M, CHVALA, R, BREZIN, J, KUMAR, A. M. S, KATZ, S. M, MCSORLEY, M, LASKOW, D. A

“…Traditionally, elderly donor kidneys have not been widely accepted for transplantation on the assumption of inferior performance. However, the United Network…”
Get full text

Impact of donor/recipient size matching on outcomes in renal transplantation by GASTON, R. S, HUDSON, S. L, JULIAN, B. A, LASKOW, D. A, DEIERHOI, M. H, SANDERS, C. E, PHILLIPS, M. G, DIETHELM, A. G, CURTIS, J. J

“…Interest in nonimmunologic factors affecting longterm graft survival has focused on adequacy of nephron dosing. Body surface are (BSA) is a reliable surrogate…”
Get full text

The role of tacrolimus in adult kidney transplantation: a review by Laskow, D A, Neylan, 3rd, J F, Shapiro, R S, Pirsch, J D, Vergne-Marini, P J, Tomlanovich, S J

“…The use of tacrolimus (FK506) in adult kidney-transplant recipients has been the subject of a number of single- and multi-center studies. This review article…”
Get more information

OKT3 first-dose reaction: Association with T cell subsets and cytokine release by Gaston, Robert S., Deierhoi, Mark H., Patterson, Trudie, Prasthofer, Edward, Julian, Bruce A., Barber, W. Henry, Laskow, David A., Diethelm, Arnold G., Curtis, John J.

“…OKT3 first-dose reaction: Association with T cell subsets and cytokine release. Use of the monoclonal antibody OKT3 to prevent or treat allograft rejection has…”
Get full text

Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression by Gaston, R S, Hudson, S L, Deierhoi, M H, Barber, W H, Laskow, D A, Julian, B A, Curtis, J J, Barger, B O, Shroyer, T W, Diethelm, A G

“…Black recipients of cadaveric kidneys have been shown to have a lower rate of allograft survival than whites. Data were reviewed from 642 primary cadaveric…”
Get more information

Phase II FK 506 multicenter concentration control study: one-year follow-up by Laskow, D A, Vincenti, F, Neylan, J, Mendez, R, Matas, A

Get more information

ATGAM Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: Patient and Graft Survival, CD3 Subset, Infection, and Cost Analysis by Kumar, M.S.A, Cahill, K, Kumar, A.M.S, Panigrahi, D, Seirka, D, Singleton, R, Al-Abdullah, I.H, Laskow, D.A

Get full text

Tapering or discontinuing cyclosporine for financial reasons--a single-center experience by Sanders, C E, Curtis, J J, Julian, B A, Gaston, R S, Jones, P A, Laskow, D A, Deierhoi, M H, Barber, W H, Diethelm, A G

“…In patients with primary cadaveric renal transplants and stable allograft function, we assessed the impact of tapering or discontinuing cyclosporine A (CsA)…”
Get more information

The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443) by Laskow, D A, Deierhoi, M H, Hudson, S L, Orr, C L, Curtis, J J, Diethelm, A G

Get more information

Experience with transplantation of elderly donor kidneys by Kumar, M.S.A., Panigrahi, D., Dezii, C.M., Laskow, D.A., Abouna, G.M., Brezin, J., Chvala, R., Katz, S.M., Phillips, K.

Get full text